TERN Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 1.50%
Insider Buying (Last 12 Months): $129,525.18
Insider Selling (Last 12 Months): $7,065,872.59

Terns Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Terns Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Terns Pharmaceuticals Share Price & Price History

Current Price: $52.95
Price Change: +0.30 (1.20%)
As of 05/5/2026 03:30 PM ET

This chart shows the closing price history over time for TERN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Terns Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2026Emil KuriakoseInsiderSell942$52.75$49,690.50105,673View SEC Filing Icon  
3/16/2026Amy L BurroughsCEOSell14,583$46.71$681,171.93288,976View SEC Filing Icon  
2/17/2026Amy L BurroughsCEOSell14,583$39.19$571,507.77288,976View SEC Filing Icon  
1/15/2026Amy L BurroughsCEOSell68,749$37.07$2,548,525.43288,976View SEC Filing Icon  
1/5/2026Amy L BurroughsCEOSell71,339$38.10$2,718,015.90138,976View SEC Filing Icon  
1/2/2026Emil KuriakoseInsiderSell1,155$38.57$44,548.3550,365View SEC Filing Icon  
11/4/2025Jill M QuigleyDirectorSell24,520$18.00$441,360.00View SEC Filing Icon  
10/1/2025Emil KuriakoseInsiderSell944$7.85$7,410.4051,520View SEC Filing Icon  
7/1/2025Emil KuriakoseInsiderSell853$4.27$3,642.3152,464View SEC Filing Icon  
6/27/2025Andrew GengosCFOBuy10,000$3.93$39,300.0025,000View SEC Filing Icon  
6/25/2025Amy L BurroughsCEOBuy23,314$3.87$90,225.1847,083View SEC Filing Icon  
6/16/2025Andrew GengosCFOBuy5,000$3.95$19,750.0015,000View SEC Filing Icon  
6/13/2025Andrew GengosCFOBuy10,000$3.73$37,300.0010,000View SEC Filing Icon  
4/1/2025Emil KuriakoseInsiderSell952$2.49$2,370.4853,317View SEC Filing Icon  
1/6/2025Jill M. QuigleyDirectorSell8,760$5.79$50,720.40View SEC Filing Icon  
1/6/2025Mark J VignolaCFOSell9,059$5.80$52,542.2074,752View SEC Filing Icon  
1/2/2025Emil KuriakoseInsiderSell4,481$5.71$25,586.5154,269View SEC Filing Icon  
1/2/2025Jill M QuigleyDirectorSell6,240$5.72$35,692.808,760View SEC Filing Icon  
1/2/2025Mark J VignolaCFOSell8,129$5.72$46,497.8883,811View SEC Filing Icon  
12/5/2024Amy L BurroughsCEOBuy15,450$7.15$110,467.5019,099View SEC Filing Icon  
11/30/2024Amy L BurroughsCEOBuy510$5.11$2,606.1019,609View SEC Filing Icon  
11/30/2024Melita Sun JungInsiderBuy2,250$5.11$11,497.502,250View SEC Filing Icon  
9/12/2024Hongbo LuDirectorBuy476,190$10.50$4,999,995.00476,190View SEC Filing Icon  
9/10/2024Mark J VignolaCFOSell10,000$11.00$110,000.0091,940View SEC Filing Icon  
9/9/2024Jill M QuigleyDirectorSell17,235$10.00$172,350.0015,000View SEC Filing Icon  
8/1/2024Jill M QuigleyDirectorSell6,143$7.68$47,178.2423,857View SEC Filing Icon  
7/15/2024Carl L GordonDirectorSell50,976$10.00$509,760.00756,258View SEC Filing Icon  
4/3/2024Vivo Opportunity, LlcMajor ShareholderSell138,066$6.20$856,009.20268,573View SEC Filing Icon  
4/1/2024Vivo Opportunity, LlcMajor ShareholderSell181,117$6.99$1,266,007.83275,772View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Terns Pharmaceuticals (NASDAQ:TERN)

98.26% of Terns Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TERN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Terns Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/15/2026Carmignac Gestion53,541$2.82M0.0%N/A0.046%Search for SEC Filing on Google Icon
5/28/2026Carlson Capital L.P.12,000$0.63M0.2%N/A0.010%Search for SEC Filing on Google Icon
5/21/2026Groupe la Francaise118,449$6.25M0.1%N/A0.103%Search for SEC Filing on Google Icon
5/20/2026Vivo Capital LLC1,334,418$70.35M5.8%-75.0%1.155%Search for SEC Filing on Google Icon
5/19/2026Bank of America Corp DE811,636$42.79M0.0%+46.6%0.703%Search for SEC Filing on Google Icon
5/19/2026Janus Henderson Group PLC1,470,057$77.51M0.0%-56.5%1.273%Search for SEC Filing on Google Icon
5/19/2026Oddo BHF Asset Management Sas5,000$0.26M0.0%N/A0.004%Search for SEC Filing on Google Icon
5/18/2026EverSource Wealth Advisors LLC3,689$0.19M0.0%+67.1%0.003%Search for SEC Filing on Google Icon
5/18/2026California State Teachers Retirement System70,219$3.70M0.0%+1,229.9%0.061%Search for SEC Filing on Google Icon
5/18/2026Royal Bank of Canada78,912$4.16M0.0%+2,470.4%0.068%Search for SEC Filing on Google Icon
5/18/2026Rock Springs Capital Management LP113,748$6M0.4%+4.9%0.098%Search for SEC Filing on Google Icon
5/18/2026Eagle Health Investments LP412,497$21.75M3.8%+49.9%0.357%Search for SEC Filing on Google Icon
5/16/2026The Manufacturers Life Insurance Company 46,784$2.47M0.0%-41.4%0.040%Search for SEC Filing on Google Icon
5/16/2026Quantinno Capital Management LP6,123$0.32M0.0%+4.7%0.005%Search for SEC Filing on Google Icon
5/16/2026Polar Asset Management Partners Inc.725,000$38.22M0.8%N/A0.628%Search for SEC Filing on Google Icon
5/16/2026SummitTX Capital L.P.312,181$16.46M0.5%+44.6%0.270%Search for SEC Filing on Google Icon
5/16/2026Lazard Asset Management LLC7,173$0.38M0.0%N/A0.006%Search for SEC Filing on Google Icon
5/15/2026Sculptor Capital LP380,000$20.03M0.2%N/A0.329%Search for SEC Filing on Google Icon
5/15/2026Octagon Capital Advisors LP530,000$27.94M3.1%N/A0.459%Search for SEC Filing on Google Icon
5/15/2026Absolute Gestao de Investimentos Ltda.230,000$12.13M1.4%N/A0.199%Search for SEC Filing on Google Icon
5/15/2026Affinity Asset Advisors LLC562,631$29.66M1.5%+2.3%0.487%Search for SEC Filing on Google Icon
5/14/2026Healthcare of Ontario Pension Plan Trust Fund924,562$48.74M0.1%-39.0%0.800%Search for SEC Filing on Google Icon
5/14/2026Renaissance Technologies LLC169,034$8.91M0.0%-63.8%0.146%Search for SEC Filing on Google Icon
5/14/2026Gabelli Funds LLC271,857$14.33M0.1%N/A0.235%Search for SEC Filing on Google Icon
5/14/2026GABELLI & Co INVESTMENT ADVISERS INC.205,700$10.85M1.6%N/A0.178%Search for SEC Filing on Google Icon
5/14/2026Caxton Associates LLP94,724$4.99M0.1%N/A0.082%Search for SEC Filing on Google Icon
5/14/2026Capula Management Ltd120,976$6.38M0.0%N/A0.105%Search for SEC Filing on Google Icon
5/14/2026Sei Investments Co.56,061$2.96M0.0%+19.0%0.049%Search for SEC Filing on Google Icon
5/14/2026DLD Asset Management LP47,025$2.48M0.2%+840.5%0.041%Search for SEC Filing on Google Icon
5/14/2026State of Wyoming1,157$61K0.0%N/A0.001%Search for SEC Filing on Google Icon
5/14/2026Monashee Investment Management LLC300,000$15.82M8.6%+52.0%0.260%Search for SEC Filing on Google Icon
5/13/2026Cetera Investment Advisers3,894$0.21M0.0%N/A0.003%Search for SEC Filing on Google Icon
5/8/2026PNC Financial Services Group Inc.2,060$0.11M0.0%+120.1%0.002%Search for SEC Filing on Google Icon
5/7/2026KBC Group NV1,683$89K0.0%N/A0.001%Search for SEC Filing on Google Icon
5/7/2026Swiss National Bank112,500$5.93M0.0%N/A0.097%Search for SEC Filing on Google Icon
5/6/2026Jennison Associates LLC501,419$26.44M0.0%N/A0.434%Search for SEC Filing on Google Icon
5/6/2026Assetmark Inc.16,157$0.85M0.0%N/A0.014%Search for SEC Filing on Google Icon
5/5/2026Bank of New York Mellon Corp281,667$14.85M0.0%+8.9%0.244%Search for SEC Filing on Google Icon
5/4/2026ABC Arbitrage SA64,303$3.39M0.5%N/A0.056%Search for SEC Filing on Google Icon
5/4/2026Principal Financial Group Inc.4,064$0.21M0.0%N/A0.004%Search for SEC Filing on Google Icon
5/1/2026Commonwealth of Pennsylvania Public School Empls Retrmt SYS20,000$1.05M0.0%N/A0.017%Search for SEC Filing on Google Icon
5/1/2026Fifth Third Bancorp605$32K0.0%N/A0.001%Search for SEC Filing on Google Icon
5/1/2026Candriam S.C.A.631,636$33.30M0.2%-50.0%0.547%Search for SEC Filing on Google Icon
4/29/2026Credit Industriel ET Commercial90,236$4.76M0.4%N/A0.078%Search for SEC Filing on Google Icon
4/28/2026Abel Hall LLC8,278$0.44M0.1%+29.4%0.007%Search for SEC Filing on Google Icon
4/27/2026Chicago Capital Management LLC129,225$6.81M0.0%N/A0.112%Search for SEC Filing on Google Icon
4/25/2026Strs Ohio16,700$0.88M0.0%-23.4%0.014%Search for SEC Filing on Google Icon
4/22/2026Pictet Asset Management Holding SA1,655,575$87.29M0.1%+5.0%1.435%Search for SEC Filing on Google Icon
4/22/2026Sterling Capital Management LLC3,184$0.17M0.0%-35.6%0.003%Search for SEC Filing on Google Icon
4/17/2026Total Clarity Wealth Management Inc.3,950$0.21M0.0%N/A0.003%Search for SEC Filing on Google Icon
4/16/2026SG Americas Securities LLC22,774$1.20M0.0%-48.1%0.020%Search for SEC Filing on Google Icon
4/16/2026E. Ohman J or Asset Management AB22,152$1.17M0.0%+4.5%0.019%Search for SEC Filing on Google Icon
3/16/2026Avoro Capital Advisors LLC4,350,000$175.74M1.7%N/A4.192%Search for SEC Filing on Google Icon
2/26/2026Seven Fleet Capital Management LP36,894$1.49M1.1%N/A0.036%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.606,247$24.49M0.0%+26.9%0.584%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp5,295$0.22M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/18/2026NewEdge Advisors LLC9,173$0.37M0.0%+240.0%0.009%Search for SEC Filing on Google Icon
2/18/2026ADAR1 Capital Management LLC541,615$21.88M1.6%+5,316.2%0.522%Search for SEC Filing on Google Icon
2/18/2026KVP Capital Advisors LP440,000$17.78M17.2%N/A0.424%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd17,032$0.69M0.0%N/A0.016%Search for SEC Filing on Google Icon
2/18/2026Ikarian Capital LLC1,596,378$64.49M5.0%+872.2%1.539%Search for SEC Filing on Google Icon
2/18/2026Vestal Point Capital LP4,500,000$181.80M6.2%N/A4.337%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC5,912$0.24M0.1%-79.6%0.006%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP788,659$31.86M0.0%+211.2%0.760%Search for SEC Filing on Google Icon
2/18/2026Squadron Capital Management LLC190,000$7.68M3.3%N/A0.183%Search for SEC Filing on Google Icon
2/18/2026SummitTX Capital L.P.215,854$8.72M0.3%+1,744.0%0.208%Search for SEC Filing on Google Icon
2/18/2026Tudor Investment Corp ET AL73,246$2.96M0.0%N/A0.071%Search for SEC Filing on Google Icon
2/18/2026Superstring Capital Management LP443,777$17.93M9.6%-43.8%0.428%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd67,266$2.72M0.0%N/A0.065%Search for SEC Filing on Google Icon
2/18/2026Orbimed Advisors LLC2,153,300$86.99M1.8%-71.5%2.075%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC987,306$39.89M0.0%+4.9%0.952%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC3,379,569$136.50M0.1%N/A3.257%Search for SEC Filing on Google Icon
2/18/2026Gotham Asset Management LLC11,476$0.46M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP16,765$0.68M0.0%N/A0.016%Search for SEC Filing on Google Icon
2/18/2026Evergreen Quality Fund GP Ltd.360,200$14.55M0.3%N/A0.347%Search for SEC Filing on Google Icon
2/18/2026Capitolis Liquid Global Markets LLC3,045,200$123.03M0.7%N/A2.935%Search for SEC Filing on Google Icon
2/18/2026Catalio Capital Management LP136,958$5.53M1.0%N/A0.132%Search for SEC Filing on Google Icon
2/18/2026Cinctive Capital Management LP70,159$2.83M0.2%-9.5%0.068%Search for SEC Filing on Google Icon
2/18/2026Commodore Capital LP1,475,000$59.59M4.0%-74.1%1.422%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.891,903$36.03M0.0%N/A0.860%Search for SEC Filing on Google Icon
2/18/2026Baker BROS. Advisors LP950,000$38.38M0.2%N/A0.916%Search for SEC Filing on Google Icon
2/18/2026Bridgeway Capital Management LLC31,000$1.25M0.0%-67.4%0.030%Search for SEC Filing on Google Icon
2/18/2026Boothbay Fund Management LLC447,008$18.06M0.3%+149.9%0.431%Search for SEC Filing on Google Icon
2/18/2026Armistice Capital LLC172,479$6.97M0.1%N/A0.166%Search for SEC Filing on Google Icon
2/17/2026Logos Global Management LP750,000$30.30M1.8%N/A0.723%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC541,615$21.88M1.6%+5,316.2%0.522%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC754,237$30.47M0.1%-60.1%0.727%Search for SEC Filing on Google Icon
2/17/2026Burkehill Global Management LP40,000$1.62M0.1%N/A0.039%Search for SEC Filing on Google Icon
2/17/2026J. Goldman & Co LP203,192$8.21M0.2%N/A0.196%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC46,324$1.87M0.0%+15.3%0.045%Search for SEC Filing on Google Icon
2/17/2026Braidwell LP575,321$23.24M0.7%N/A0.554%Search for SEC Filing on Google Icon
2/17/2026Abel Hall LLC6,395$0.26M0.1%N/A0.006%Search for SEC Filing on Google Icon
2/17/2026Jain Global LLC95,124$3.84M0.0%N/A0.092%Search for SEC Filing on Google Icon
2/17/2026Paradigm Biocapital Advisors LP810,286$32.74M0.8%N/A0.781%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP150,049$6.06M0.1%+292.6%0.145%Search for SEC Filing on Google Icon
2/17/2026Nearwater Capital Markets Ltd1,704,800$68.87M1.2%N/A1.643%Search for SEC Filing on Google Icon
2/17/2026Farallon Capital Management LLC642,000$25.94M0.1%N/A0.619%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD974,312$39.36M0.0%+934.6%0.939%Search for SEC Filing on Google Icon
2/17/2026Rock Springs Capital Management LP108,481$4.38M0.2%N/A0.105%Search for SEC Filing on Google Icon
2/17/2026Integral Health Asset Management LLC425,000$17.17M0.8%-55.3%0.410%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Terns Pharmaceuticals logo
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Read More on Terns Pharmaceuticals

Today's Range

Now: $52.95
Low: $52.94
High: $52.98

50 Day Range

MA: $51.03
Low: $42.00
High: $53.17

52 Week Range

Now: $52.95
Low: $2.65
High: $53.19

Volume

6,347,000 shs

Average Volume

4,844,130 shs

Market Capitalization

$6.12 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Terns Pharmaceuticals?

Terns Pharmaceuticals' top insider shareholders include:
  1. Orbimed Advisors Llc (Director)
  2. Vivo Opportunity, Llc (Major Shareholder)
  3. Hongbo Lu (Director)
  4. Carl L Gordon (Director)
  5. Biosciences Fund V LP Lav (Major Shareholder)
  6. Amy L Burroughs (CEO)
  7. Emil Kuriakose (Insider)
  8. Mark J Vignola (CFO)
  9. Andrew Gengos (CFO)
  10. Jill M Quigley (Director)
Learn More about top insider investors at Terns Pharmaceuticals.

Who are the major institutional investors of Terns Pharmaceuticals?

Terns Pharmaceuticals' top institutional shareholders include:
  1. Pictet Asset Management Holding SA — 1.43%
  2. Janus Henderson Group PLC — 1.27%
  3. Vivo Capital LLC — 1.16%
  4. Healthcare of Ontario Pension Plan Trust Fund — 0.80%
  5. Bank of America Corp DE — 0.70%
  6. Polar Asset Management Partners Inc. — 0.63%
Learn More about top institutional investors of Terns Pharmaceuticals stock.

Which institutional investors are selling Terns Pharmaceuticals stock?

Within the last quarter, TERN stock was sold by these institutional investors:
  1. Vivo Capital LLC
  2. Janus Henderson Group PLC
  3. Candriam S.C.A.
  4. Healthcare of Ontario Pension Plan Trust Fund
  5. Renaissance Technologies LLC
  6. The Manufacturers Life Insurance Company
  7. SG Americas Securities LLC
  8. Strs Ohio
Within the last year, company insiders that have sold Terns Pharmaceuticals company stock include:
  1. Amy L Burroughs (CEO)
  2. Emil Kuriakose (Insider)
  3. Jill M Quigley (Director)
Learn More investors selling Terns Pharmaceuticals stock.

Which institutional investors are buying Terns Pharmaceuticals stock?

In the previous quarter, TERN stock was acquired by institutional investors including:
  1. Polar Asset Management Partners Inc.
  2. Octagon Capital Advisors LP
  3. Jennison Associates LLC
  4. Sculptor Capital LP
  5. Gabelli Funds LLC
  6. Bank of America Corp DE
  7. Absolute Gestao de Investimentos Ltda.
  8. GABELLI & Co INVESTMENT ADVISERS INC.
During the last year, these company insiders have bought Terns Pharmaceuticals stock:
  1. Hongbo Lu (Director)
  2. Amy L Burroughs (CEO)
  3. Andrew Gengos (CFO)
  4. Melita Sun Jung (Insider)
Learn More investors buying Terns Pharmaceuticals stock.